As a fitting wrap up to its first year of publication, Hepatology Communications, AASLD’s online Open Access journal, has been accepted to PubMed Central.
“This is a major milestone, because the application itself requires that the journal show at least 25 peer-reviewed research articles, and most importantly has to show an ongoing and regular publication record with high quality papers,” said Gyongyi Szabo, MD, PhD, FAASLD, Editor of Hepatology Communications.
Additionally, she noted, the journal’s inclusion in PubMed serves as a benefit to readers because now all articles published in the journal from the first issue forward are easily searched and discoverable.
The relatively quick pathway to inclusion in PubMed is another milestone because the journal reached this achievement in its first year.
“This indicates enthusiasm for this journal, both from authors and also from the standpoint of the Associate Editors who really put a lot of effort into making this happen,” said Dr. Szabo.
Hepatology Communications’ inclusion in PubMed puts it on the same playfield as many other scientific journals, she noted, and provides the journal’s content to readers and researchers all over the world.
“Hopefully there will be citations that are generated by this new information. We believe this is going to be an engine for increasing the number of submissions, and increasing the value of journal overall,” she added.
Dr. Szabo credits the close working relationship with AASLD’s flagship journal HEPATOLOGY as well as the hard work of the editorial team and AASLD publications staff and Journals Publications Committee for the quick success of the journal.
However, the PubMed acceptance is just the critical first step in the journal’s path toward indexing and an Impact Factor.
“The Medline application is something we will submit next,” said Dr. Szabo. “We have to publish at least 12 months worth of issues first, so we hope that will be something that we can submit in spring of 2018. Once Medline indexing is in place, then that will slowly bring us to the indexing in the Web of Science and also applying to the Emerging Science Citation Index, which is essentially a requirement for reaching an Impact Factor.”
This process will ideally be accomplished in three years, she said.
“The shortest possible time to get an Impact Factor is three years. With ongoing support of our authors and editorial team and the quality of papers that we are enjoying, I think we have full confidence that we should be able to get an Impact Factor in three years.”
Dr. Szabo and the Associate Editor team are currently working on building the Editorial Board as well as creatively brainstorming ways to take advantage of the journal’s online presence.
“Now that the journal is listed in PubMed, I hope people will be even more enthusiastic about submitting manuscripts to the journal because now anything that is published is available to the entire scientific community. I’m hoping there is going to be a self perpetuating cascade and growth, because if we have more manuscripts, then certainly we can distribute information more effectively to our readers,” she said.